Extended-spectrum beta-lactamase (ESBL)-producing enterobacteria: factors associated with infection in the community setting, Auckland, New Zealand
- PMID: 18353497
- DOI: 10.1016/j.jhin.2008.02.003
Extended-spectrum beta-lactamase (ESBL)-producing enterobacteria: factors associated with infection in the community setting, Auckland, New Zealand
Abstract
We aimed to document the epidemiology of extended-spectrum beta-lactamase (ESBL)-producing enterobacteria in the Auckland community and identify factors associated with infection using a case-control study design. ESBL-producing enterobacteria were isolated from 107 infected patients, for which demographic and clinical data were available for 98 cases (92%). Escherichia coli was the predominant organism (82%), with urine as the commonest source (97%). Compared with a control group infected with ESBL-negative enterobacteria, factors significantly associated with infection on univariate analysis were: living in a residential care home (RCH); recent admission to hospital 'M'; recent antibiotic use; older age (>75 years); presence of a urinary catheter; and a history of comorbid chronic obstructive pulmonary disease (COPD), cardiovascular disease, neurological disease or recurrent urinary tract infection. On multivariate analysis, residence in RCH and COPD remained significant associations. Pulsed-field gel electrophoresis typing of the ESBL-producing E. coli identified a common strain. We concluded that residence in RCH and a history of COPD are significant associations with ESBL-producing enterobacterial infection in the Auckland community. Several spatial clusters in RCHs and a common strain suggest point-source outbreaks. A substantial number of community cases did not live in an RCH nor had been recently hospitalised, suggesting the independent generation of ESBL-producing enterobacteria in the broader community.
Similar articles
-
Nationwide survey of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae in the French community setting.J Antimicrob Chemother. 2009 Jun;63(6):1205-14. doi: 10.1093/jac/dkp108. Epub 2009 Mar 28. J Antimicrob Chemother. 2009. PMID: 19329798
-
A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients.Clin Infect Dis. 2009 Sep 1;49(5):682-90. doi: 10.1086/604713. Clin Infect Dis. 2009. PMID: 19622043
-
Activity of ertapenem and other antimicrobials against ESBL-producing enterobacteria isolated from urine in patients from Madrid.Rev Esp Quimioter. 2007 Sep;20(3):334-8. Rev Esp Quimioter. 2007. PMID: 18080031
-
Clinical significance of extended-spectrum beta-lactamases.Expert Rev Anti Infect Ther. 2008 Oct;6(5):671-83. doi: 10.1586/14787210.6.5.671. Expert Rev Anti Infect Ther. 2008. PMID: 18847405 Review.
-
Extended-spectrum beta-lactamases in ambulatory care: a clinical perspective.Clin Microbiol Infect. 2008 Jan;14 Suppl 1:104-10. doi: 10.1111/j.1469-0691.2007.01866.x. Clin Microbiol Infect. 2008. PMID: 18154533 Review.
Cited by
-
Differences in risk-factor profiles between patients with ESBL-producing Escherichia coli and Klebsiella pneumoniae: a multicentre case-case comparison study.Antimicrob Resist Infect Control. 2014 Sep 1;3:27. doi: 10.1186/2047-2994-3-27. eCollection 2014. Antimicrob Resist Infect Control. 2014. PMID: 25237477 Free PMC article.
-
Bacteremia caused by extended-spectrum-β-lactamase-producing Escherichia coli sequence type ST131 and non-ST131 clones: comparison of demographic data, clinical features, and mortality.Antimicrob Agents Chemother. 2012 Feb;56(2):618-22. doi: 10.1128/AAC.05753-11. Epub 2011 Nov 28. Antimicrob Agents Chemother. 2012. PMID: 22123694 Free PMC article.
-
Risk factors for community-acquired urinary tract infections caused by ESBL-producing enterobacteriaceae--a case-control study in a low prevalence country.PLoS One. 2013 Jul 23;8(7):e69581. doi: 10.1371/journal.pone.0069581. Print 2013. PLoS One. 2013. PMID: 23936052 Free PMC article.
-
Community-associated extended-spectrum β-lactamase-producing Escherichia coli infection in the United States.Clin Infect Dis. 2013 Mar;56(5):641-8. doi: 10.1093/cid/cis942. Epub 2012 Nov 13. Clin Infect Dis. 2013. PMID: 23150211 Free PMC article.
-
Urinary tract infection in infants caused by extended-spectrum beta-lactamase-producing Escherichia coli: comparison between urban and rural hospitals.Pediatr Nephrol. 2016 Aug;31(8):1305-12. doi: 10.1007/s00467-016-3338-0. Epub 2016 Mar 14. Pediatr Nephrol. 2016. PMID: 26975387
MeSH terms
Substances
LinkOut - more resources
Full Text Sources